Parallel18

What Parallel18 does

Parallel18 is a Puerto Rico-based international startup accelerator and investment platform founded in 2015 and operated by the Puerto Rico Science, Technology and Research Trust, a private non-profit. It serves early-stage startups from Puerto Rico and international markets, providing funding, mentorship, business training, and investor and corporate connections. The organization has supported over 600 startups cumulatively and distributed $13.3M in seed capital.

The platform operates four core programs targeting distinct stages and verticals: P18, the flagship international acceleration program offering $100K SAFE investments in a 16-week cohort; BioLeap, a life sciences incubation program providing lab access at The Confluence Center; Xpand, a growth-stage community program for Puerto Rican companies with $250K+ revenue, subsidized by Banco Popular; and VCAP, a venture capital access program deploying $150K-$2.5M equity co-investments backed by a $30M SSBCI allocation. Supporting programs include the Matching Fund for follow-on capital and the Connect Program for corporate-startup introductions.

In 2026, after ten years as a grant-based accelerator, Parallel18 executed a strategic transition to a structured investment platform, replacing non-dilutive grants with SAFE investments and expanding its capital deployment range via VCAP. The business model is hybrid: grant funding from PRSTRT and public programs covers operations, corporate partnerships (Banco Popular) subsidize specific programs, and long-term returns on equity stakes in portfolio companies provide a sustainable capital recycling mechanism. Revenue is not publicly disclosed, consistent with its non-profit structure and public-mission mandate.

Name

Parallel18

Legal name

Parallel18 (Puerto Rico Science, Technology, and Research Trust)

Website

https://parallel18.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Parallel18 is a Puerto Rico-based startup accelerator and investment platform operating P18, BioLeap, Xpand, and VCAP programs. It supports early-stage international and local startups with funding, mentorship, and corporate connections, having supported over 600 startups since 2015.

Ownership category

akta.pro rank

Product category

Startup Acceleration & Investment

NAICS

Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)

SIC

Finance Services (6199), Federal & Federally-Sponsored Credit Agencies (6111)

akta.pro primary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

akta.pro secondary industries

Corporate Accelerators & Startup Programs (FSANAHAD), Development Finance & Blended Finance Facilities (BPADAOAD)

Keywords

• Startup acceleration
• Venture capital access
• Startup investment platform
• Life sciences incubation
• Growth-stage scaling

Headquarters

HQ city

San Juan

HQ country

Puerto Rico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment Returns (SAFEs and Equity): Parallel18 invests in startups via Simple Agreements for Future Equity (SAFEs) and equity positions. P18 invests $100K per startup; VCAP invests $150K-$2.5M per company. Returns are generated when portfolio companies succeed through exits, acquisitions, or continued growth, creating a sustainable capital cycle for supporting future entrepreneurs.
2. Grant Funding (Puerto Rico Science, Technology and Research Trust): The program is funded by the Puerto Rico Science, Technology, and Research Trust, a private non-profit organization. Funding supports operational costs and direct investments in startups. Xpand is subsidized by Banco Popular.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

Parallel18 is a startup accelerator and investment platform that operates multiple programs (P18 international acceleration, BioLeap life sciences incubation, Xpand growth-stage program, and VCAP venture capital access) offering early-stage and growth-stage startups seed/SAFE investments, mentorship, business training, corporate introductions, and investor networking. It is a program of the Puerto Rico Science, Technology and Research Trust and supports startups with capital ranging from $100K SAFE investments up to $2.5M equity rounds.

Product overview

Parallel18 is a multi-program startup investment platform operated by the Puerto Rico Science, Technology and Research Trust. The platform consists of four core programs: P18 (international acceleration), BioLeap (life sciences incubation), Xpand (growth-stage community), and VCAP (venture capital access). These programs are designed to support startups at different stages—from early-stage international founders (P18) to Puerto Rican life science researchers (BioLeap) to established local companies seeking to scale (Xpand)—with investment capital, mentorship, and corporate connectivity. The platform also includes a Matching Fund for follow-on investments and a Connect Program for corporate-startup partnerships. The overall architecture supports startups from pre-acceleration through growth stage, creating a comprehensive ecosystem for building globally competitive companies from Puerto Rico.

Differentiator

Problem solved

Functional benefit

Brands

• P18: International startup acceleration program offering $100K investment via SAFE for early-stage startups from around the world, operating from Puerto Rico.
• BioLeap
• Xpand
• VCAP
• Parallel18 Ventures

Products and services

• P18 Acceleration Program International startup acceleration program investing $100K via SAFE in early-stage startups (3 years or less operations). 16-week curriculum including bootcamps, mentorship, weekly KPI follow-ups, investment immersion, and Demo Day. Targets startups incorporated in Puerto Rico or the US that relocate to Puerto Rico for the program duration.
• BioLeap Life Sciences Incubation Life sciences incubation program with 12-week curriculum plus 14-week technical assistance period. Drives scientific research and innovation toward commercialization in biotechnology, agrotech, medtech, bioengineering, medical devices, and digital health. Includes access to The Confluence Center fully equipped laboratory in Science City. All services are free to participants.
• Xpand Growth-Stage Program Growth-stage community program subsidized by Banco Popular. Supports Puerto Rican companies with 3+ years of operations and $250K+ annual sales with free resources including bootcamps, investment readiness assessment, technical assistance, roundtable meetings, and networking. Applications open year-round.
• VCAP (Venture Capital Access Program) Direct equity co-investment mechanism deploying SSBCI funds. Invests $150K to $2.5M in Pre-Seed, Seed, and Series A rounds of Puerto Rican companies, providing up to 50% of any given round with 1:1 matching from private investors. Focus sectors include Biopharmaceuticals, FinTech, Energy, Manufacturing, DeepTech, AI, and Travel & Tourism.
• Parallel18 Ventures Matching Fund Follow-on capital program that co-invests alongside private investors in top parallel18 alumni. Identifies startups with highest global scale potential and provides additional capital support beyond the initial program investment. The Matching Fund has supported multiple portfolio companies with $858,000 raised by alumni.
• Parallel18 Connect Corporate Partnership Program

Quantifiable outcome

• 320 companies graduated from P18 with 41.3% being Puerto Rican
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core, major and minor.

• Puerto Rico Science, Technology and Research TrustcoreStrategic or Co-development Partner · 1 January 2015Parent organization that created and funds parallel18. A private non-profit created to maximize Puerto Rico's participation in the global knowledge economy by promoting investment and financing of science and technology research development. Manages over a dozen initiatives including grants, technical support, meetups, and educational resources.
• Corporate Partners (multiple)majorStrategic or Co-development PartnerLong-term strategic collaborations with key players in the startup ecosystem. Partners include multiple corporations across industries that participate in industry meetups, provide seed capital, and engage in business development with startups through the Connect program. Multiple logos displayed indicating active corporate partnerships.
• The Confluence CenterminorStrategic or Co-development PartnerFully equipped laboratory facility located in the Forward Building (parallel18 headquarters) in Science City. Provides BioLeap participants with dedicated space and specialized instruments for running experiments.

Scale indicators18 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• IndieBio: Life sciences accelerator program operated by SOSV with intensive cohort-based biotech commercialization support. The closest direct comparable to Parallel18's BioLeap vertical.
• MassChallenge: Global nonprofit startup accelerator with similar mission of supporting early-stage founders across multiple verticals through mentorship, corporate partnerships, and equity-free programs. Most directly comparable on nonprofit, multi-program, international accelerator model.
• Techstars: Large global accelerator network with mentorship-driven 3-month cohorts and accelerator-week demo days. Comparable as a multi-stage venture support platform with corporate partner integration.
• SOSV: Multi-stage venture capital fund operating vertical-specific accelerator programs (including IndieBio for biotech — directly relevant to Parallel18's BioLeap program) with similar cohort-based investment model.
• Start-Up Chile: Government-backed startup accelerator program based in Chile providing equity-free funding to international founders. Highly comparable as a state-sponsored, international-focused, non-dilutive or low-dilution accelerator.
• Plug and Play: Global innovation platform combining accelerator programs with corporate venture and startup-corporate matchmaking (similar to Parallel18 Connect). Operates industry-specific verticals with international presence.
• BioGenerator: Nonprofit life sciences investor and accelerator supporting biotech startups from lab to commercialization, including laboratory access. Comparable to Parallel18's BioLeap program in mission, lab-enabled incubation, and nonprofit life sciences venture model.
• Y Combinator: Benchmark startup accelerator offering standardized SAFE-based investment in batches with demo day. The reference point for Parallel18's pivot to SAFE-based equity investment in P18.
• 500 Global (500 Startups): Global venture firm and accelerator operating programs across emerging markets including Latin America. Direct peer given international cohort model and early-stage equity investment approach.

Regional players

• Wayra (Telefónica): Corporate-backed startup accelerator operating across Latin America and Europe with equity investment and corporate partnership focus. Comparable as a regional LATAM accelerator with similar bridge-market positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/p18startups
• YouTubeyoutube.com/watch?v=XJ95oC0lN0g
• Facebookfacebook.com/p18startups
• LinkedInlinkedin.com/company/parallel18

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments162 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parallel18